Skip to main content
. 2020 Feb 12;10:2494. doi: 10.1038/s41598-020-59225-7

Figure 3.

Figure 3

SNS314 mesylate (SNS314 M), an inhibitor phosphorylation of histone H3 at serine 10 (phospho-H3S10), reduces cell viability (A) and proliferation (B) in a dose dependent manner in hCPCs untreated and treated with ticagrelor (Tic 1 μM). Higher dose of SNS314 M (10 μM) counteracts ticagrelor (Tic 1 μM) effects (A,B). SNS314 M 10 μM counteract effects of Tic 1 μM on levels of phospho-H3S10/H3 ratio (C) without altering expression of P2Y12 (D; 52KDa MW) of hCPCs. Levels of phospho-H3S10, H3 and P2Y12 are normalized on glyceraldehyde 3-phosphate dehydrogenase (GAPDH) levels and expressed as arbitrary units (a.u.). Representative images of cropped densitometric bands of proteins phospho-H3S10, H3, P2Y12 and GAPDH are showed in panel E. The full-length blots/gels are presented in Supplemental Fig. 7 panel A. All measurements are mean ± SD. *p < 0.05 vs. untreated condition (Vehicle: sterile phosphate buffer solution); #p < 0.05 vs. Tic 1 μM; §p < 0.05 vs. SNS314 M (10 μM).